This immunodeficiency, if untreated, makes GSD Ib patients susceptible to infection.[2] The principal treatment for this feature of GSD Ib is filgrastim; however, patients often still require treatment for frequent infections, and a chronically enlarged spleen is a common side effect.[3] GSD Ib patients often present with inflammatory bowel disease.[4]